Epilepsy and inborn errors of metabolism in children

Journal of Inherited Metabolic Disease

Volumn 32, Issue 5, 2009, Pages 609-617

  Wolf, N I ^a   Garcia Cazorla A ^b,c   Hoffmann, G F ^d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HOSPITAL SANT JOAN DE DÉU   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYSINE; BIOTIN; CREATINE; DNA DIRECTED DNA POLYMERASE GAMMA; FOLINIC ACID; GLUCOSE TRANSPORTER 1; GLYCINE AMIDINOTRANSFERASE; GUANIDINOACETATE METHYLTRANSFERASE; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAMINE PHOSPHATE OXIDASE; PYRIDOXINE; SERINE; SUCCINATE SEMIALDEHYDE DEHYDROGENASE;

CEREBROSPINAL FLUID ANALYSIS; DRUG EFFICACY; ENZYME DEFICIENCY; ENZYME THERAPY; EPILEPSY; EPILEPTIC STATE; EVOKED CORTICAL RESPONSE; GENE MUTATION; HUMAN; HYPERAMMONEMIA; HYPERINSULINISM; INBORN ERROR OF METABOLISM; ONSET AGE; REVIEW; SEIZURE; SINGLE DRUG DOSE;

ADOLESCENT; AGE OF ONSET; CHILD; EPILEPSY; HUMANS; INFANT, NEWBORN; METABOLISM, INBORN ERRORS;

EID: 70350294125     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-009-1171-3     Document Type: Review

References (22)

1. Bahi-Buisson N, Kaminska A, Nabbout R, et al (2006a) Epilepsy in Menkes disease: Analysis of clinical stages. Epilepsia 47: 380-386. doi: 10.1111/j.1528-1167.2006.00432.x
2. Bahi-Buisson N, Mention K, Leger PL, et al (2006b) Neonatal epilepsy and inborn errors of metabolism. Arch Pediatr 13: 284-292. doi: 10.1016/ j.arcped.2005.10.024
3. Bahi-Buisson N, El Sabbagh S, Soufflet C, et al (2008) Myoclonic absence epilepsy with photosensitivity and a gain of function mutation in glutamate dehydrogenase. Seizure 17: 658-664. doi: 10.1016/ j.seizure.2008.01.005
4. de Koning TJ, Klomp LW (2004) Serine-deficiency syndromes. Curr Opin Neurol 17: 197-204. doi: 10.1097/00019052-200404000-00019
5. de Koning TJ, Klomp LW, van Oppen AC, et al (2004) Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency. Lancet 364: 2221-2222. doi: 10.1016/S0140-6736(04)17596-X
6. Farrant RD, Walker V, Mills GA, Mellor JM, Langley GJ (2001) Pyridoxal phosphate de-activation by pyrroline-5-carboxylic acid. Increased risk of vitamin B 6 deficiency and seizures in hyperprolinemia type II. J Biol Chem 276: 15107-15116. doi: 10.1074/jbc.M010860200
7. Gallagher RC, Van Hove JL, Scharer G, et al (2009) Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy. Ann Neurol 65: 5550-556.
8. Hoffmann GF, Schmitt B, Windfuhr M, et al (2007) Pyridoxal 5′-phosphate may be curative in early-onset epileptic encephalopathy. J Inherit Metab Dis 30: 96-99. doi: 10.1007/ s10545-008-9974-1
9. Mercimek-Mahmutoglu S, Stoeckler-Ipsiroglu S, Adami A, et al (2006) GAMT deficiency: Features, treatment, and outcome in an inborn error of creatine synthesis. Neurology 67: 480-484. doi: 10.1212/ 01.wnl.0000234852.43688.bf
10. Mills PB, Surtees RA, Champion MP et al (2005) Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5′-phosphate oxidase. Hum Mol Genet 14: 1077-1086. doi: 10.1093/hmg/ddi120
11. Mills PB, Struys E, Jakobs C, et al (2006) Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med 12: 307-309. doi: 10.1038/nm1366
12. Mudd SH, Skovby F, Levy HL, et al (1985) The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 37: 1-31.
13. Pearl PL, Gibson KM, Acosta MT, et al (2003) Clinical spectrum of succinic semialdehyde dehydrogenase deficiency. Neurology 60: 1413-1417.
14. Plecko B, Stockler-Ipsiroglu S, Paschke E, Erwa W, Struys EA, Jakobs C (2000) Pipecolic acid elevation in plasma and cerebrospinal fluid of two patients with pyridoxine-dependent epilepsy. Ann Neurol 48: 121-125. doi: 10.1002/1531-8249(200007)48:1<121::AID-ANA20>3.0.CO;2-V
15. Salbert BA, Pellock JM, Wolf B (1993) Characterization of seizures associated with biotinidase deficiency. Neurology 43: 1351-1355.
16. Schulze A, Ebinger F, Rating D, Mayatepek E (2001) Improving treatment of guanidinoacetate methyltransferase deficiency: Reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation. Mol Genet Metab 74: 413-419. doi: 10.1006/ mgme.2001.3257
17. Sedel F, Gourfinkel-An I, Lyon-Caen O, Baulac M, Saudubray JM, Navarro V (2007) Epilepsy and inborn errors of metabolism in adults: A diagnostic approach. J Inherit Metab Dis 30: 846-854. doi: 10.1007/s10545-007-0723-7
18. Seidner G, Alvarez MG, Yeh JI, et al (1998) GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat Genet 18: 188-191. doi: 10.1038/ng0298-188
19. Stockler S, Schutz PW, Salomons GS (2007) Cerebral creatine deficiency syndromes: Clinical aspects, treatment and pathophysiology. Subcell Biochem 46: 149-166. doi: 10.1007/978-1-4020-6486-9_8
20. Surtees R, Wolf N (2007) Treatable neonatal epilepsy. Arch Dis Child 92: 659-661. doi: 10.1136/adc.2007.116913
21. Wolf NI, Bast T, Surtees R (2005) Epilepsy in inborn errors of metabolism. Epileptic Disord 7: 67-81.
22. Wolf NI, Rahman S, Schmitt B, et al (2009) Status epilepticus in children with Alpers' disease caused by POLG1 mutations: EEG and MRI features. Epilepsia 50: 1596-1607. doi: 10.1111/j.1528-1167.2008.01877.x